Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Compass Pathways Plc ADR (CMPS)

Compass Pathways Plc ADR (CMPS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
COMPASS Pathways Reports Before Its FDA Timeline Becomes More Than a Projection Barchart - Wed Jul 29, 4:06PM CDT

Barchart Research What to Expect from CMPS Earnings CMPS Generated July 29, 2026 Current Price $10.90 EPS Estimate $$-0.46 Consensus Rating Strong Buy Average Move 10.06% COMPASS Pathways Reports Before...

CMPS : 10.90 (+0.46%)
Compass Pathways to Announce Second Quarter and First Half 2026 Financial Results on August 5, 2026 Business Wire - Wed Jul 29, 5:30AM CDT

Compass Management will host a conference call at 8:00 am ET (1:00 pm UK)

CMPS : 10.90 (+0.46%)
Billions Flow Into Next-Generation Depression Treatments as Pharma Innovation Accelerates FinancialNewsMedia - Tue Jul 21, 7:30AM CDT

EQNX::TICKER_START (NASDAQ:HELP),(NASDAQ:CMPS),(NASDAQ:ATAI),(NYSE:JNJ),(NYSE:LLY) EQNX::TICKER_END

HELP : 7.91 (+4.08%)
CMPS : 10.90 (+0.46%)
ATAI : 7.18 (unch)
JNJ : 265.53 (-0.45%)
LLY : 1,210.02 (-0.87%)
Compass Pathways Announces Publication of Post-Hoc Analysis Demonstrating Distinction of COMP360 Trial Monitoring & Support from Psychotherapy Business Wire - Thu Jul 16, 5:35AM CDT

Post-hoc analysis of support methods used in an open-label Phase 2 COMP360 study showed monitoring and support provided during treatment administration sessions were minimal, non-directive and distinct...

CMPS : 10.90 (+0.46%)
Compass Pathways Announces Six-Month Data from Second Phase 3 Trial Confirming Rapid and Durable Profile Business Wire - Tue Jul 7, 5:30AM CDT

New 6-month data supports COMP360’s potential to establish a new standard of care in TRD Data from positive COMP006 Phase 3 trial demonstrates durable...

CMPS : 10.90 (+0.46%)
Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire - Thu Jul 2, 5:30AM CDT

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that Compass granted equity awards under...

CMPS : 10.90 (+0.46%)
Multi-Billion-Dollar Battle for the Future of Depression Treatment Has Begun Creating a Huge Opportunity FinancialNewsMedia - Tue Jun 30, 8:00AM CDT

EQNX::TICKER_START (NASDAQ:HELP),(NASDAQ:DFTX),(NASDAQ:CMPS),(NASDAQ:GHRS),(NYSE:JNJ) EQNX::TICKER_END

HELP : 7.91 (+4.08%)
CMPS : 10.90 (+0.46%)
GHRS : 27.98 (+0.07%)
JNJ : 265.53 (-0.45%)
DFTX : 42.16 (+0.48%)
Multi-Billion-Dollar Battle for the Future of Depression Treatment Has Begun Creating a Huge Opportunity GlobeNewswire - Tue Jun 30, 8:00AM CDT

NEW YORK, June 30, 2026 (GLOBE NEWSWIRE) -- Market News Updates News Commentary - The way Major Depressive Disorder (MDD) is treated is changing faster than it has in years. For decades, most patients...

HELP : 7.91 (+4.08%)
CMPS : 10.90 (+0.46%)
GHRS : 27.98 (+0.07%)
JNJ : 265.53 (-0.45%)
DFTX : 42.16 (+0.48%)
Kailera Therapeutics Appoints Kathleen Tregoning as Chief Corporate Affairs Officer GlobeNewswire - Mon Jun 29, 6:30AM CDT

WALTHAM, Mass., June 29, 2026 (GLOBE NEWSWIRE) -- Kailera Therapeutics, Inc., a clinical-stage biotechnology company focused on elevating the next era of obesity care, today announced the appointment...

CMPS : 10.90 (+0.46%)
KLRA : 16.88 (+0.84%)
SPRO : 1.1900 (-0.42%)
Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire - Fri Jun 5, 5:30AM CDT

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that Compass granted equity awards under...

CMPS : 10.90 (+0.46%)

Barchart Exclusives

This Dividend Stock Is Up 22% in a Month Despite Mixed Q2 Earnings. Don’t Sell Just Yet. Barchart - Wed Jul 29, 6:30PM CDT
Domino’s Pizza stock has rebounded sharply from its 2026 lows. While its valuation multiples have expanded and DPZ does not look as tempting now, dividend investors can stay put in the stock. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.